Short answer · Medically reviewed summary · Last updated: 2026-04-07
Ankylosing Spondylitis is not strictly hereditary in a simple Mendelian sense, but it is strongly influenced by genetics, particularly the presence of the HLA-B27 gene variant. While it is considered a multifactorial condition—meaning it results from a complex interaction between genetic predisposition and environmental triggers—having a first-degree relative with the disease significantly increases an individual's risk. Is Ankylosing Spondylitis considered a genetic or hereditary condition? Ankylosing Spondylitis is best described as a complex, multifactorial condition rather than a strictly hereditary one.
10 people with Ankylosing Spondylitis have shared their first-person experience on this question at DiseaseMaps.
Ankylosing Spondylitis is not strictly hereditary in a simple Mendelian sense, but it is strongly influenced by genetics, particularly the presence of the HLA-B27 gene variant. While it is considered a multifactorial condition—meaning it results from a complex interaction between genetic predisposition and environmental triggers—having a first-degree relative with the disease significantly increases an individual's risk.
Ankylosing Spondylitis is best described as a complex, multifactorial condition rather than a strictly hereditary one. This means it does not follow a simple pattern like autosomal dominant or recessive inheritance. Instead, it arises from a combination of genetic factors and environmental influences. The most well-known genetic association is with the Human Leukocyte Antigen B27 (HLA-B27) gene. While many people who carry the HLA-B27 gene never develop the disease, its presence is a significant marker for genetic susceptibility to Ankylosing Spondylitis.
Because Ankylosing Spondylitis is multifactorial, it is difficult to provide an exact percentage of inheritance. However, research suggests that the risk for a child of an affected parent is higher than that of the general population. While the general population risk is less than 1%, the risk for a first-degree relative of someone with Ankylosing Spondylitis is estimated to be between 5% and 10%. It is important to remember that inheriting the HLA-B27 gene does not guarantee that a person will develop Ankylosing Spondylitis, as other genes and external triggers likely play a role in disease onset.
Genetic testing for the HLA-B27 antigen is available and is often used by physicians as a diagnostic tool, but it is not a standalone test for Ankylosing Spondylitis. A positive result confirms the presence of the gene, which is found in approximately 80–90% of patients with the condition in certain populations, but a negative result does not rule out the disease. Clinical diagnosis relies more heavily on a combination of physical examination, patient history, and imaging (such as X-rays or MRIs of the sacroiliac joints) than on genetic screening alone.
Genetic counseling is highly recommended for families concerned about the recurrence of Ankylosing Spondylitis. A genetic counselor can provide a personalized risk assessment, help interpret the clinical significance of HLA-B27 testing, and offer emotional support for those navigating the complexities of chronic illness. Because de novo (spontaneous) mutations are not the primary driver of this condition, counseling focuses more on understanding family history and managing expectations regarding the multifactorial nature of the disease.
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.